FDA Approves TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN — Aurobindo Pharma Limited
The FDA has granted approval to Aurobindo Pharma Limited for its generic Tramadol Hydrochloride oral product, marking a new competitive entry into the opioid analgesic market. This ANDA approval is expected to broaden manufacturer portfolios and drive price competition for the widely prescribed opioid combination therapy.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day